U.S. Top Stock Picks from Analysts

UnitedHealth Group

Market Cap: US$343.6b

Operates as a health care company in the United States and internationally.

Marvell Technology

Market Cap: US$55.9b

Provides data infrastructure semiconductor solutions, spanning the data center core to network edge.

JD.com

Market Cap: US$48.8b

Operates as a supply chain-based technology and service provider in the People’s Republic of China.

BioMarin Pharmaceutical

Market Cap: US$11.8b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Moderna

Market Cap: US$9.4b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

AST SpaceMobile

Market Cap: US$8.9b

Designs and develops the constellation of BlueBird satellites in the United States.

VinFast Auto

Market Cap: US$8.7b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

Roivant Sciences

Market Cap: US$7.8b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.

Revolution Medicines

Market Cap: US$7.8b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Corcept Therapeutics

Market Cap: US$7.7b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

UWM Holdings

Market Cap: US$6.8b

Engages in the origination, sale, and servicing residential mortgage lending in the United States.

BridgeBio Pharma

Market Cap: US$6.8b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Jazz Pharmaceuticals

Market Cap: US$6.4b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Legend Biotech

Market Cap: US$5.9b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

EchoStar

Market Cap: US$5.8b

Provides networking technologies and services in the United States and internationally.

Lantheus Holdings

Market Cap: US$5.7b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Ionis Pharmaceuticals

Market Cap: US$5.3b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Axsome Therapeutics

Market Cap: US$5.3b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Nuvalent

Market Cap: US$5.0b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

ChampionX

Market Cap: US$5.0b

Provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide.

Icahn Enterprises

Market Cap: US$4.8b

Through its subsidiaries engages in the investment, energy, automotive, food packaging, real estate, home fashion and pharma in the United States and internationally.

BGC Group

Market Cap: US$4.5b

Operates as a financial brokerage and technology company in the United States, Europe, the Middle East, Africa, and the Asia Pacific.

Onto Innovation

Market Cap: US$4.3b

Engages in the design, development, manufacture, and support of process control tools that performs optical metrology and inspection worldwide.

Vaxcyte

Market Cap: US$4.1b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Krystal Biotech

Market Cap: US$4.0b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Telephone and Data Systems

Market Cap: US$4.0b

A telecommunications company, provides communications services to consumer, business, and government in the United States.

Cytokinetics

Market Cap: US$3.8b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Sarepta Therapeutics

Market Cap: US$3.6b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

GEO Group

Market Cap: US$3.5b

Owns, leases, operates, and manages secure facilities, processing centers, and community-based reentry facilities in the United States, Australia, the United Kingdom, and South Africa.

Zeta Global Holdings

Market Cap: US$3.4b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

Avidity Biosciences

Market Cap: US$3.4b

A biopharmaceutical company, engages in the delivery of RNA therapeutics.

Ultragenyx Pharmaceutical

Market Cap: US$3.3b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Akero Therapeutics

Market Cap: US$3.3b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

Arcellx

Market Cap: US$3.3b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Liberty Global

Market Cap: US$3.2b

Provides broadband internet, video, fixed-line telephony, and mobile communications services to residential and business customers.

Zai Lab

Market Cap: US$3.2b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.